Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management
International Journal of Molecular Sciences · 16.03.2026 · 27 (6) · 2704
DOI: 10.3390/ijms27062704 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.03.2026. Verfasst von Chun Hsiung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tri-Service General Hospital, Taipei 114202, Taiwan. Hauptthemen laut MEDLINE: Glaucoma, Energy Metabolism, Oxygen Consumption, Leukocytes, Mononuclear. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital Research Foundation, National Defense Medical Center Foundation, National Defense Medical University (National Defense Medical Center) Foundation.
Abstract (Originalsprache)
Glaucoma is a multifaceted optic neuropathy, characterized by the progressive loss of retinal ganglion cells. This damage frequently continues even after intraocular pressure (IOP) has been effectively lowered. This resistance to conventional IOP-lowering therapy underscores the critical role of interacting IOP-independent mechanisms; specifically metabolic failure and systemic mitochondrial dysfunction have emerged as key parallel drivers. This review analyzes the paradigm shift from a pressure-centric model to a bioenergetic one, focusing on mitochondrial function, peripheral blood mononuclear cell (PBMC) biomarkers, and oxygen consumption dynamics. We synthesize evidence demonstrating that glaucoma patients exhibit a metabolic vulnerability, characterized by lower PBMC oxygen consumption rates and depleted systemic nicotinamide adenine dinucleotide levels relative to healthy individuals. Furthermore, compromised systemic respiratory performance correlates with more rapid worsening of visual fields and structural thinning, independent of IOP status. Moreover, we delineate the role of Complex I defects, SARM1-mediated axonal degeneration, and proteomic alterations, which indicate defective mitophagy. These findings establish systemic metabolic profiling as a valuable supplementary tool for assessing patient risk and support the clinical translation of neuroprotective therapies targeting mitochondrial bioenergetics, specifically nicotinamide, pyruvate, coenzyme Q10, and metformin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Tri-Service General Hospital, Taipei 114202, Taiwan.
- Department of Ophthalmology, College of Medicine, National Defense Medical University, Taipei 114202, Taiwan.
- Department of General Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei 114202, Taiwan.
ORCID-Profile: Chun Hsiung, Ta-Hung Chiu, Wei-Ting Yen
Förderung
- Tri-Service General Hospital Research Foundation
- National Defense Medical Center Foundation
- National Defense Medical University (National Defense Medical Center) Foundation
- Teh-Tzer Study Group for Human Medical Research Foundation
Zitieren
APA
Hsiung, C., Chiu, T. H., Yen, W. T., & Lu, D. W. (2026). Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management. International Journal of Molecular Sciences, 27(6), 2704. https://doi.org/10.3390/ijms27062704
Vancouver
Hsiung C, Chiu TH, Yen WT, Lu DW. Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management. International Journal of Molecular Sciences. 2026;27(6):2704. doi:10.3390/ijms27062704
BibTeX
@article{Hsiung2026,
author = {Hsiung, Chun and Chiu, Ta-Hung and Yen, Wei-Ting and Lu, Da-Wen},
title = {Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2704},
doi = {10.3390/ijms27062704}
}
EUVIMED